Literature DB >> 11191137

The biology of Kaposi's sarcoma.

B Herndier1, D Ganem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11191137     DOI: 10.1007/978-1-4615-1601-9_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  22 in total

1.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.

Authors:  Jianhong Hu; Alexander C Garber; Rolf Renne
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm.

Authors:  Eric Bortz; Lili Wang; Qingmei Jia; Ting-Ting Wu; Julian P Whitelegge; Hongyu Deng; Z Hong Zhou; Ren Sun
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

4.  K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function.

Authors:  Tyson V Sharp; Hsei-Wei Wang; Andrew Koumi; Daniel Hollyman; Yoshio Endo; Hongtao Ye; Ming-Qing Du; Chris Boshoff
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  Virology       Date:  2011-02-25       Impact factor: 3.616

6.  Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

Authors:  Michael Pearce; Satoko Matsumura; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

8.  Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).

Authors:  Satoko Matsumura; Yuriko Fujita; Evan Gomez; Naoko Tanese; Angus C Wilson
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

9.  Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.

Authors:  Johanna R Abend; Thomas Uldrick; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

10.  Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.

Authors:  Jaehyuk Yoo; Jinjoo Kang; Ha Neul Lee; Berenice Aguilar; Darren Kafka; Sunju Lee; Inho Choi; Juneyong Lee; Swapnika Ramu; Juergen Haas; Chester J Koh; Young-Kwon Hong
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.